Harmony Biosciences (HRMY) · page 211 of 366
The slide uses a table from a Lancet paper to argue that pitolisant's performance was inferior to modafinil, contradicting the company's narrative.
Research note · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 paragraph 2/2 source-note 1/1 table 1/1
Components 5
primary paragraph paragraph source-note data
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.